PRP for Tennis Elbow (Lateral Epicondylitis): A Patient's Complete Guide

Tennis elbow (lateral epicondylitis) is the textbook example of a tendinopathy that responds well to PRP. The evidence base is among the strongest in regenerative medicine, the procedure is straightforward, and the comparison to traditional cortisone injection comes out clearly in PRP's favor over any meaningful time horizon.

This guide walks through what tennis elbow actually is, why the cortisone-first approach has fallen out of favor, what PRP does biologically, what the procedure and recovery look like, and what realistic outcomes are. The guide applies to medial epicondylitis (golfer's elbow) too; the biology and treatment principles are essentially the same.

What tennis elbow actually is

Tennis elbow is degenerative tendinopathy at the common extensor tendon origin, where the wrist and finger extensor muscles attach to the lateral epicondyle of the elbow. The classic site of pathology is the extensor carpi radialis brevis (ECRB) tendon.

The condition is misnamed. Most people who get it don't play tennis. The same biology develops in anyone doing repetitive gripping, wrist extension, or pronation: carpenters, electricians, office workers, mothers carrying small children, gardeners, surgeons, dentists, mechanics. Tennis is one trigger among many.

Despite the older "epicondylitis" terminology, the underlying problem isn't classical inflammation. Histologic studies of tennis elbow tendons show degenerative changes (disorganized collagen, neovascularization, mucoid degeneration) rather than the cellular inflammatory infiltrate you'd expect in true tendinitis. This is part of why anti-inflammatory medications and cortisone produce limited durable benefit; they're addressing a problem that isn't really inflammatory.

The contemporary term "tendinopathy" reflects this. The treatment paradigm has shifted accordingly.

How it typically presents

Lateral elbow pain, often gradual in onset, sometimes triggered by a specific activity. Worse with gripping, lifting (especially with the palm down), wrist extension against resistance, shaking hands. Often tender to palpation over the lateral epicondyle and the immediately adjacent extensor tendon.

The pain can be mild and intermittent or severe and constant. Many patients tolerate it for months before seeking care, by which point the tendinopathy is well-established and conservative care alone is less likely to fully resolve it.

Patients commonly report difficulty with daily tasks: holding a coffee cup, opening jars, turning a doorknob, using a computer mouse, picking up a child. The functional impact can be substantial even when the pain itself isn't severe.

The natural history

Untreated tennis elbow often resolves on its own, but slowly. Studies of conservative management report meaningful improvement by 12 to 18 months in most patients, with a minority continuing to have symptoms beyond 2 years.

The patients who do best with watchful waiting tend to be those with mild disease, recent onset, ability to modify the inciting activity, and reasonable conditioning otherwise. The patients who don't are often the ones who can't fully modify the activity (their job depends on it), who have advanced tendinopathy on imaging, or who have failed multiple courses of conservative care.

The role of injection-based therapy is to accelerate recovery and reduce the cumulative disability. The question is which injection.

Why cortisone has fallen out of favor

For decades, the standard of care for tennis elbow was a corticosteroid injection. It still is in many primary care and sports medicine practices. The pattern is reliable: rapid (2 to 4 week) symptomatic improvement followed by gradual symptom recurrence and, with repeated injections, worsening of the underlying tendon.

The landmark Coombes RCT (JAMA 2013) compared cortisone, sham injection, PT, and combinations in patients with unilateral lateral epicondylalgia. At 1 year, the cortisone group had worse outcomes than the placebo group on multiple measures, including recurrence rate. The finding has been reproduced in other trials.

Mechanistically, cortisone suppresses the local repair response. In a tendon that's degenerating because of failed repair, suppressing the repair response provides temporary symptomatic relief while worsening the underlying biology. Each subsequent cortisone injection in the same tendon raises the risk of long-term tendon rupture and persistent degenerative change.

The pattern isn't subtle: cortisone trades long-term tendon quality for short-term relief. For patients who need short-term relief and don't care about long-term tendon health (the patient with a wedding next month, the surgeon who needs to operate this week), a single cortisone injection can still be the right answer. For everyone else, there's a better option.

What PRP does for tennis elbow

PRP delivers the body's growth-factor signaling cargo directly into the degenerating tendon. The platelets release growth factors that initiate a controlled inflammatory cascade, which over weeks drives tendon repair: fibroblast recruitment, collagen synthesis, neovascular ingrowth (which can normalize the aberrant neovascularization of established tendinopathy), and remodeling of the disorganized collagen architecture.

The biology takes time. Unlike cortisone (which produces relief in days), PRP produces relief over weeks to months. The early post-procedure period can include a brief flare in symptoms as the controlled inflammatory cascade activates. This is expected and resolves within days.

For tennis elbow specifically, we use leukocyte-rich PRP (LR-PRP). The included white cells contribute to the controlled inflammatory burst that the tendon environment needs to initiate repair. (For intra-articular joint work, we use leukocyte-poor PRP for different reasons; the formulation matters and varies by indication.)

The evidence base

Multiple RCTs comparing PRP to corticosteroid in tennis elbow:

Mishra (2014). Multicenter RCT, 230 patients, single PRP injection vs needling control. At 24 weeks, the PRP group had significantly better pain and elbow tenderness scores.

Peerbooms and colleagues (2010, 2014, 2017). Original RCT and long-term follow-up: PRP outperformed cortisone at 1 year and at 2 years on pain and function scores.

Multiple meta-analyses (Krogh 2013, Hurley 2020, others). PRP consistently shows superiority over cortisone at 6 and 12 months, with effect sizes that are clinically meaningful.

Comparison to PT alone. PRP plus PT shows modest superiority over PT alone in most studies, particularly for chronic recalcitrant cases.

Comparison to autologous blood injection. Earlier studies used autologous whole blood (less concentrated than PRP); these showed positive results that PRP has largely replaced in current practice.

The cumulative literature places tennis elbow among the most evidence-supported PRP indications. If a clinic is offering PRP for any indication, tennis elbow should be among them.

The Apex protocol

For tennis elbow at Apex:

Workup. Confirm the diagnosis on exam (Cozen's test, Maudsley's test, palpation of the lateral epicondyle). Ultrasound evaluation of the tendon to assess severity and rule out a tendon tear that might change the recommendation. Sometimes MRI for atypical presentations.

The procedure. 60 to 75 minutes total. Blood draw (about 30 mL into specialized tubes). Centrifuge processing to produce leukocyte-rich PRP at concentration appropriate for tendon work. Sterile prep of the lateral elbow. Local anesthetic for comfort. Ultrasound-guided injection of PRP into the affected tendon, with the needle position visualized throughout. We use a fenestration technique (multiple small passes through the tendon) to maximize PRP distribution within the tissue and to provoke a controlled mechanical signal that supplements the biological one.

Post-procedure. 24 to 72 hours of local soreness, sometimes a brief inflammatory flare in the first few days. Acetaminophen for symptom control. No NSAIDs for 5 to 7 days post-procedure (they blunt the inflammatory cascade that's part of the therapeutic effect). Ice if needed.

Activity restriction. No heavy gripping, racquet sports, or heavy lifting for the first 4 to 6 weeks. Light daily activity, computer work, and most non-loading activity is fine.

Rehabilitation. Structured PT starting around week 2 to 3 post-procedure, with a progressive eccentric loading program for the wrist extensors. The combination of PRP plus eccentric loading has stronger evidence than either alone.

Follow-up. Re-evaluation at 6 weeks and again at 12 weeks. If response is incomplete at 6 to 8 weeks and there's evidence of partial improvement, a second injection is sometimes appropriate.

What recovery actually looks like

Days 1 to 5. Soreness around the injection site, sometimes more pronounced than expected. Functional limitation similar to baseline.

Week 1. Soreness settling. Sometimes a brief return of pre-procedure symptoms. Activity restrictions in place.

Weeks 2 to 3. Beginning of structured eccentric loading PT. Symptoms variable.

Weeks 4 to 6. First signs of symptomatic improvement for most patients. Activity restrictions begin to loosen.

Weeks 8 to 12. Clearer improvement. Most responders are clearly better by 12 weeks. Return to most normal activity.

Months 3 to 6. Peak response. Continued improvement in some patients through this window.

Months 6 to 12. Durable response in most patients who reached good improvement at 3 to 6 months.

Patients who haven't shown clear improvement by 12 weeks are candidates for either a second injection (if there's partial response and clinical reasoning to expect more), a different modality (shockwave, surgical consultation), or a re-evaluation of the diagnosis.

When PRP isn't the right answer

A few scenarios:

Complete tendon rupture. Surgical repair, not PRP. Rare in tennis elbow but it happens, particularly after multiple prior cortisone injections.

Pure mechanical/radial nerve compression mimicking tennis elbow. Radial tunnel syndrome can present similarly. Requires different workup and treatment.

Acute (less than 4 to 6 weeks) onset. Conservative care first. Acute tendinopathy may resolve with rest and modification.

Severe pain disproportionate to imaging findings. Consider other diagnoses or contributors.

Coagulopathy or anticoagulation that prevents PRP. Some patients on blood thinners can't undergo PRP safely without bridging.

The cortisone vs PRP decision

A useful framework for patients trying to decide:

If you need fast relief and don't care about long-term tendon quality (single use, specific short-term goal), cortisone is reasonable.

If you've already had one or more cortisone injections and the relief is shortening or you're concerned about long-term tendon health, switch to PRP.

If this is your first injection-based treatment, PRP is the better starting point for durable results.

If cost is a barrier and you're between cortisone (often covered by insurance) and PRP (cash-pay), you can try cortisone once with a clear understanding of the trade-off, then move to PRP if needed.

When shockwave fits in

Some chronic refractory tennis elbow cases benefit from a shockwave course either as a standalone treatment or as priming before PRP. (More in our shockwave guide.) Shockwave has its own published evidence base for lateral epicondylitis, with results roughly comparable to PRP in some trials. For the patient who's failed both conservative care and a PRP attempt, shockwave is the typical next step.

When surgery becomes relevant

Tennis elbow surgery (open or arthroscopic release of the ECRB tendon, often with debridement of degenerated tissue) is reserved for the small percentage of patients who fail conservative care, PRP, and shockwave. Recovery from tennis elbow surgery is 6 to 12 weeks, and the results in head-to-head comparisons aren't dramatically better than well-conducted non-surgical care. Most patients who reach surgical consideration have very chronic, very refractory cases.

What you can do at home

Alongside any injection-based treatment, a few evidence-supported steps:

Activity modification. Identify the inciting activity and modify it temporarily. Counter-force braces (the strap worn just below the elbow) can help during activities that provoke pain.

Eccentric loading. Progressive wrist extensor strengthening with eccentric (lengthening) emphasis. A structured PT program is more effective than self-directed; we provide a written program for patients who don't have access to PT.

Ergonomic evaluation. For desk workers, addressing keyboard, mouse, and monitor positioning often helps.

Patience. Tendons heal slowly. The PRP procedure starts a process; the process takes 3 to 6 months to complete.

Specific patient profiles

The 48-year-old tennis player with chronic right elbow pain after a season of more aggressive play. Typical PRP candidate. Single injection, structured rehab, return to play in 3 to 4 months.

The 55-year-old surgeon with progressive elbow pain over 2 years and two failed cortisone injections. Chronic case, may need PRP plus shockwave plus a structured rehab program. Realistic timeline 4 to 6 months to substantial improvement.

The 35-year-old new mother with tennis elbow from carrying her infant. PRP with activity modification advice. The inciting activity (lifting the baby) can't fully be eliminated, which sometimes slows recovery.

The 67-year-old retired contractor with multiple comorbidities and elbow pain. PRP plus careful review of other tendinopathies and contributing factors.

How to book

To request a consultation about your elbow, request a consultation or call (972) 768-2328. We're at 2111 Kirkwood Blvd, Suite 110b, Southlake, TX 76092.

If you've had multiple cortisone shots and are considering whether PRP is still worth trying, the answer is usually yes. Bring the imaging if you have it.

A short note from Dr. Abdullah

Tennis elbow is the indication where I'm most often able to give patients a clean, evidence-supported recommendation that matches well to outcomes. The procedure is straightforward, the evidence is solid, the patient typically responds, and the alternative (more cortisone, eventually surgery) doesn't compete well over a 5-year horizon. For most patients with chronic tennis elbow that's interfering with their life, PRP is the right next step. The hardest part is the 12-week patience while the biology does its work.